Literature DB >> 1707793

Pyridoxine-dependent epilepsy: EEG investigations and long-term follow-up.

M A Mikati1, E Trevathan, K S Krishnamoorthy, C T Lombroso.   

Abstract

The EEG features and clinical correlates were investigated before, directly after, and on long-term follow-up after initiation of pyridoxine therapy in 6 patients with B6-dependent epilepsy. At each phase, the EEG provided important diagnostic and prognostic information. Pre-B6 3 neonates manifested a unique EEG pattern of generalized bursts of 1-4 Hz sharp and slow activity. This pattern has not been previously described in neonates with B6 dependency and in this age group appears to be highly suggestive of the diagnosis. Five patients experienced an apparent initial response to traditional antiepileptics. The parenteral pyridoxine test, performed in all 5, and repeated in 3, proved to be a highly reliable and reproducible diagnostic test. After 50-100 mg of B6 there was cessation of clinical seizures within minutes and of paroxysmal discharges within hours. On long-term follow-up (3-28 years) all 6 patients were seizure free on B6 (10-100 mg/day) monotherapy. Recurrences of seizures and of specific sequential EEG changes (background slowing, photoparoxysmal response, spontaneous discharges, stimulus-induced myoclonus, generalized seizures) occurred upon B6 withdrawal. Long-term prognosis correlated with the EEG. Two patients had persistently abnormal EEG backgrounds and were moderately to severely retarded, while 4 had normal EEGs with normal or near normal development.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1707793     DOI: 10.1016/0013-4694(91)90035-3

Source DB:  PubMed          Journal:  Electroencephalogr Clin Neurophysiol        ISSN: 0013-4694


  14 in total

Review 1.  Neonatal seizures.

Authors:  D Evans; M Levene
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-01       Impact factor: 5.747

2.  Fits, pyridoxine, and hyperprolinaemia type II.

Authors:  V Walker; G A Mills; S A Peters; W L Merton
Journal:  Arch Dis Child       Date:  2000-03       Impact factor: 3.791

3.  Phenotype, biochemical features, genotype and treatment outcome of pyridoxine-dependent epilepsy.

Authors:  Amal Al Teneiji; Theodora U J Bruun; Dawn Cordeiro; Jaina Patel; Michal Inbar-Feigenberg; Shelly Weiss; Eduard Struys; Saadet Mercimek-Mahmutoglu
Journal:  Metab Brain Dis       Date:  2016-11-23       Impact factor: 3.584

Review 4.  Diagnosis and treatment of epilepsy in children and adolescents.

Authors:  L D Morton; J M Pellock
Journal:  Drugs       Date:  1996-03       Impact factor: 9.546

5.  Pyridoxine dependent epilepsy: a suggestive electroclinical pattern.

Authors:  R Nabbout; C Soufflet; P Plouin; O Dulac
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-09       Impact factor: 5.747

6.  Efficacy of pyridoxine in early-onset idiopathic intractable seizures in children.

Authors:  Devendra Mishra; Veena Kalra; Rachna Seth; Sheffali Gulati; Narayan Saha
Journal:  Indian J Pediatr       Date:  2010-09-10       Impact factor: 1.967

7.  Clinical features and the management of pyridoxine-dependent and pyridoxine-responsive seizures: review of 63 North American cases submitted to a patient registry.

Authors:  Gregory J Basura; Shawn P Hagland; Anna M Wiltse; Sidney M Gospe
Journal:  Eur J Pediatr       Date:  2008-09-02       Impact factor: 3.183

8.  The loss of circadian PAR bZip transcription factors results in epilepsy.

Authors:  Frédéric Gachon; Philippe Fonjallaz; Francesca Damiola; Pascal Gos; Tohru Kodama; Jozsef Zakany; Denis Duboule; Brice Petit; Mehdi Tafti; Ueli Schibler
Journal:  Genes Dev       Date:  2004-06-02       Impact factor: 11.361

Review 9.  Pediatric neurotransmitter diseases.

Authors:  Phillip L Pearl; Denise D Wallis; K Michael Gibson
Journal:  Curr Neurol Neurosci Rep       Date:  2004-03       Impact factor: 5.081

Review 10.  Nodding syndrome: A key role for sources of nutrition?

Authors:  P S Spencer; C Okot; V S Palmer; R Valdes Angues; R Mazumder
Journal:  eNeurologicalSci       Date:  2022-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.